Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

LIXTLIXT
5 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in LIXTE BIOTECHNOLOGY HLDGS IN

WELLS FARGO & COMPANY/MN holds 5 shares of LIXT (LIXTE BIOTECHNOLOGY HLDGS IN), worth $37 as of 2026-Q2. This is a new position.

Current Value

$37

Current Shares

5

Total Value Change

+$15

Total Shares Change

-4

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
5
-
$370.0%$7.42
17
2024-Q2
Exited
0
-100.0%
$00.0%$2.37
0
2024-Q1
Unchanged
9
0.0%
$300.0%$3.38
0
2023-Q4
Unchanged
9
0.0%
$210.0%$2.35
0
2023-Q3
New
9
-
$220.0%$2.45
17

Other major holders of LIXT: VANGUARD CAPITAL MANAGEMENT LLC, SCOTIA CAPITAL INC., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used